{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T18:53:54Z","timestamp":1720983234009},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.mehy.2012.12.037","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T09:46:51Z","timestamp":1359625611000},"page":"441-446","source":"Crossref","is-referenced-by-count":5,"title":["Neo-endocrinochemotherapy: A novel approach for enhancing chemotherapeutic efficacy in clinic?"],"prefix":"10.1016","volume":"80","author":[{"given":"Jianbo","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guosheng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kainan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingquan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2012.12.037_b0005","first-page":"9","article-title":"Cell cycle perturbation and acquired 5-fluorouracil chemoresistance","volume":"28","author":"Guo","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1016\/j.mehy.2012.12.037_b0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2265.2007.02813.x","article-title":"Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the late effects surveillance system","volume":"66","author":"Paulides","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.mehy.2012.12.037_b0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0022-3476(05)80288-4","article-title":"Thyroid function after treatment of brain tumors in children","volume":"119","author":"Ogilvy-Stuart","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.mehy.2012.12.037_b0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/B:BREA.0000010708.99455.e1","article-title":"Fatigue, weight gain, lethargy and amenorrhea in breast cancer patients on chemotherapy: is subclinical hypothyroidism the culprit?","volume":"83","author":"Kumar","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.mehy.2012.12.037_b0025","first-page":"397","article-title":"The thyroid gland function assessment in women after mastectomy and chemotherapy during breast cancer therapy","volume":"58","author":"Majkowska-Mlynarczyk","year":"2007","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.mehy.2012.12.037_b0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJM200107263450406","article-title":"Clinical practice. Subclinical hypothyroidism","volume":"345","author":"Cooper","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2012.12.037_b0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2265.1982.tb00720.x","article-title":"Alterations in thyroid hormone metabolism during chemotherapy in patients with testicular carcinoma","volume":"16","author":"Willemse","year":"1982","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.mehy.2012.12.037_b0040","doi-asserted-by":"crossref","unstructured":"Cohen LE. Endocrine late effects of cancer treatment. Endocrinol Metab Clin North Am 2005;34:769\u201389, xi.","DOI":"10.1016\/j.ecl.2005.04.008"},{"key":"10.1016\/j.mehy.2012.12.037_b0045","first-page":"624","article-title":"Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer","volume":"47","author":"Jordan","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2012.12.037_b0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2265.2001.01297.x","article-title":"Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy","volume":"55","author":"Howell","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.mehy.2012.12.037_b0055","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00008480-200108000-00011","article-title":"Endocrine complications of neoplastic diseases in children and adolescents","volume":"13","author":"Gleeson","year":"2001","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.mehy.2012.12.037_b0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/1097-0142(20010201)91:3<613::AID-CNCR1042>3.0.CO;2-R","article-title":"High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood","volume":"91","author":"Kenney","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.mehy.2012.12.037_b0065","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1023\/A:1012464703805","article-title":"Male gonadal dysfunction in patients with Hodgkin\u2019s disease prior to treatment","volume":"12","author":"Rueffer","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.mehy.2012.12.037_b0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0268-960X(02)00042-5","article-title":"Endocrine complications in pediatric patients with acute lymphoblastic leukemia","volume":"16","author":"Howard","year":"2002","journal-title":"Blood Rev"},{"key":"10.1016\/j.mehy.2012.12.037_b0075","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/pbc.20485","article-title":"Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation","volume":"46","author":"Haddy","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.mehy.2012.12.037_b0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mpo.2950250208","article-title":"Chemotherapy-induced growth hormone deficiency in children with cancer","volume":"25","author":"Roman","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.mehy.2012.12.037_b0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1515\/JPEM.2004.17.1.55","article-title":"Hypothalamic dysfunction after chemotherapy","volume":"17","author":"Rose","year":"2004","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.mehy.2012.12.037_b0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/annonc\/mdf059","article-title":"Oestrogen\/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications","volume":"13","author":"Stoll","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.mehy.2012.12.037_b0095","first-page":"339","article-title":"Local arterial infusion of 5-FU in treatment of acute necrotic pancreatitis","volume":"33","author":"Gu","year":"1995","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"10.1016\/j.mehy.2012.12.037_b0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.14310\/horm.2002.11177","article-title":"Insulin resistance, growth factors and cytokine levels in overweight women with breast cancer before and after chemotherapy","volume":"5","author":"Chala","year":"2006","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.mehy.2012.12.037_b0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1467-789X.2011.00957.x","article-title":"Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms","volume":"13","author":"Gadea","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/j.mehy.2012.12.037_b0110","doi-asserted-by":"crossref","unstructured":"Pascual A, Aranda A. Thyroid hormone receptors, cell growth and differentiation. Biochim Biophys Acta 2012 [Epub ahead of print].","DOI":"10.1016\/j.bbagen.2012.03.012"},{"key":"10.1016\/j.mehy.2012.12.037_b0115","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1210\/en.140.11.5267","article-title":"Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin\/cyclin-dependent kinase levels and activity","volume":"140","author":"Barrera-Hernandez","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2012.12.037_b0120","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1038\/sj.onc.1208126","article-title":"Unliganded thyroid hormone receptor beta1 inhibits proliferation of murine fibroblasts by delaying the onset of the G1 cell-cycle signals","volume":"23","author":"Porlan","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.mehy.2012.12.037_b0125","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M005492200","article-title":"Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1","volume":"276","author":"Duan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2012.12.037_b0130","first-page":"5387","article-title":"Effect of alpha-interferon, 17 beta-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF 7 cells","volume":"50","author":"Bezwoda","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2012.12.037_b0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1210\/en.142.1.147","article-title":"Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase","volume":"142","author":"Jeay","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2012.12.037_b0140","first-page":"3570","article-title":"Perturbation by insulin of human breast cancer cell cycle kinetics","volume":"44","author":"Gross","year":"1984","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2012.12.037_b0145","doi-asserted-by":"crossref","first-page":"e6428","DOI":"10.1371\/journal.pone.0006428","article-title":"Hypothyroidism enhances tumor invasiveness and metastasis development","volume":"4","author":"Martinez-Iglesias","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2012.12.037_b0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbrc.2011.09.024","article-title":"Thyroid hormone differentially modulates Warburg phenotype in breast cancer cells","volume":"414","author":"Suhane","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2012.12.037_b0155","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/0277-5379(88)90329-X","article-title":"Oestradiol enhances doxorubicin uptake and cytotoxicity in human breast cancer cells (MCF-7)","volume":"24","author":"Bontenbal","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.mehy.2012.12.037_b0160","first-page":"1327","article-title":"Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy","volume":"44","author":"Emerman","year":"1984","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2012.12.037_b0165","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2460\/ajvr.2000.61.646","article-title":"Effects of treatment with growth hormone and somatostatin on efficacy of diammine [1,1-cyclobutane dicarboxylato (2-)-0,0\u2032]-(SP-4-2) in athymic rats with osteosarcoma","volume":"61","author":"Conzemius","year":"2000","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.mehy.2012.12.037_b0170","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11596-010-0555-9","article-title":"Insulin in endometrial carcinoma chemotherapy: a beneficial addition and not a problem","volume":"30","author":"Sha","year":"2010","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.mehy.2012.12.037_b0175","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1745-7254.2007.00554.x","article-title":"Pretreatment with insulin enhances anticancer functions of 5-fluorouracil in human esophageal and colonic cancer cells","volume":"28","author":"Zou","year":"2007","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.mehy.2012.12.037_b0180","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1447-0756.2008.00770.x","article-title":"Uterine choriocarcinoma accompanied by an extremely high human chorionic gonadotropin level and thyrotoxicosis","volume":"34","author":"Hsieh","year":"2008","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.mehy.2012.12.037_b0185","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00001813-199607000-00001","article-title":"Remission of refractory gestational trophoblastic disease with high-dose paclitaxel","volume":"7","author":"Termrungruanglert","year":"1996","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.mehy.2012.12.037_b0190","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(03)14073-1","article-title":"Hyperthyroidism","volume":"362","author":"Cooper","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2012.12.037_b0215","unstructured":"Hershman JM.Trophoblastic tumors. In: Braverman LEUtiger RD, editor. The thyroid. 7th ed. Philadelphia:Lippincott-Raven, 1995:573-6."},{"key":"10.1016\/j.mehy.2012.12.037_b0200","first-page":"711","article-title":"Low dose chemotherapy in combination with insulin for the treatment of advanced metastatic tumors. Preliminary experience","volume":"14","author":"Damyanov","year":"2009","journal-title":"J BUON"},{"key":"10.1016\/j.mehy.2012.12.037_b0205","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1054\/mehy.2000.1063","article-title":"Insulin, chemotherapy, and the mechanisms of malignancy: the design and the demise of cancer","volume":"55","author":"Ayre","year":"2000","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2012.12.037_b0210","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.nut.2010.06.008","article-title":"Treatment with growth hormone, somatostatin, and insulin in combination with hypocaloric parenteral nutrition in gastrointestinal cancer patients after surgery","volume":"27","author":"Liu","year":"2011","journal-title":"Nutrition"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713000261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713000261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T02:50:57Z","timestamp":1539917457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987713000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0306987713000261"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2012.12.037","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}